Trials / Completed
CompletedNCT03681808
Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism
A Study to Evaluate the Safety and Effectiveness of the Biotrue ONEday for Astigmatism Soft Contact Lens When Worn on a Daily Basis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 242 (actual)
- Sponsor
- Bausch & Lomb Incorporated · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Comparing Test Lens for Astigmatism Soft Contact Lens (Test) to 1-Day Control for Astigmatism contact lenses (Control).
Detailed description
This is a multicenter, randomized 1:1, parallel-group, bilateral, Investigator-masked study at 13 investigative sites in the United States (US) in a population including Chinese subjects (maternal and paternal grandparents born in China)
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Control | Contact Lens |
| DEVICE | Test | Soft Contact Lens |
Timeline
- Start date
- 2018-10-10
- Primary completion
- 2019-12-16
- Completion
- 2019-12-16
- First posted
- 2018-09-24
- Last updated
- 2021-01-08
- Results posted
- 2020-12-17
Locations
13 sites across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03681808. Inclusion in this directory is not an endorsement.